Deborah J.R. Hankey

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

Gareth Pryce, Zubair Ahmed, Deborah J.R. Hankey et al. · Brain · 2003 · 340 citations · Full text

Immunology, Immune Regulation, Inflammatory Attack +20

Inhibition of Rho GTPases with Protein Prenyltransferase Inhibitors Prevents Leukocyte Recruitment to the Central Nervous System and Attenuates Clinical Signs of Disease in an Animal Model of Multiple Sclerosis

Claire E. Walters, Gareth Pryce, Deborah J.R. Hankey et al. · The Journal of Immunology · 2002 · 114 citations · Full text

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors

Jason W. Brooks, Gareth Pryce, Tiziana Bisogno et al. · European Journal of Pharmacology · 2002 · 82 citations

Cannabis Use, Health Sciences, Functional Selectivity +15

Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis

Gareth Pryce, J.K. O'Neill, J. Ludovic Croxford et al. · Journal of Neuroimmunology · 2005 · 77 citations

Autoimmune Disease, Allergy, Autoimmune Tolerance +10

Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction

Matthew E. Gegg, Rachel A. Harry, Deborah J.R. Hankey et al. · The Journal of Immunology · 2005 · 67 citations · Full text